Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity

Adropin, a secretory signal peptide, has shown beneficial effects on improving glucose homeostasis and dyslipidemia. However, whether this peptide affects nonalcoholic steatohepatitis (NASH) has remained unclear. In this study, the serum adropin levels, liver injury and oxidative stress were measure...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xu, Xue, Hongliang, Fang, Wanjun, Chen, Ke, Chen, Shen, Yang, Wenqi, Shen, Tianran, Chen, Xuechen, Zhang, Peiwen, Ling, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351233/
https://www.ncbi.nlm.nih.gov/pubmed/30684890
http://dx.doi.org/10.1016/j.redox.2018.101068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351233/
https://www.ncbi.nlm.nih.gov/pubmed/30684890
http://dx.doi.org/10.1016/j.redox.2018.101068

Ejemplares similares